Physician

Jeffrey John Kelly, D.O.

According to 2025 Medicare claims, Jeffrey Kelly, D.O. (NPI: 1770565384) practices dermatology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is ASSOCIATES IN DERMATOLOGY OF TRAVERSE CITY PC (NPI: 1861430779; TIN: 383526691) and primary practice location at 49684-7760. Kelly is affiliated with the Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

Kelly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 878 traditional Medicare patients, billed 3,942 HCPCS/CPT codes, and received $161,887 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 1,720 prescription claims across 622 beneficiaries totaling $1,440,574 in drug costs, led by Stelara (Ustekinumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $142,583 to $1,440,574. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,096	4,433	$176,749
2016	1,100	4,290	$176,586
2017	1,196	4,809	$185,693
2018	1,336	5,914	$207,718
2019	1,266	6,074	$224,112
2020	971	4,767	$173,937
2021	974	4,612	$178,192
2022	919	4,139	$162,459
2023	891	4,237	$165,676
2024	878	3,942	$161,887

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	470	1,186	$142,583
2016	585	1,455	$356,490
2017	622	1,666	$421,744
2018	660	1,773	$1,012,066
2019	658	1,814	$1,076,684
2020	560	1,672	$1,121,098
2021	576	1,655	$1,211,779
2022	608	1,647	$1,408,038
2023	650	1,758	$1,356,681
2024	622	1,720	$1,440,574

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	117	117	$71
11102	Biopsy of related skin growth, first growth	146	154	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	687	887	$62
17000	Destruction of precancer skin growth, 1 growth	404	479	$42
17003	Destruction of precancer skin growth, 2-14 growths	303	1,686	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	17	1,302	$454,285
Enbrel Sureclick	Etanercept	28	784	$312,028
Humira(Cf) Pen	Adalimumab	11	308	$134,696
Cosentyx Sensoready (2 Pens)	Secukinumab	14	392	$118,382
Otezla	Apremilast	20	600	$102,501

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jeffrey John Kelly, D.O.?

Tedicare shows public-source Medicare data for Jeffrey John Kelly, D.O. (NPI 1770565384), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey John Kelly, D.O. have ACO affiliation data?

Jeffrey John Kelly, D.O. is shown with ACO affiliation data for Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to Jeffrey John Kelly, D.O.?

Jeffrey John Kelly, D.O. is linked to ASSOCIATES IN DERMATOLOGY OF TRAVERSE CITY PC (billing NPI 1861430779) in the available physician profile data.

Does Jeffrey John Kelly, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.